1027617-67-9

Basic information

• Product Name: 2,5,6,7-TETRAHYDRO-2-METHYL-4H-INDAZOL-4-ONE
• Synonyms: 2,5,6,7-TETRAHYDRO-2-METHYL-4H-INDAZOL-4-ONE;2-methyl-6,7-dihydro-5H-indazol-4-one
• CAS NO: 1027617-67-9
• Molecular Formula: C8H10N2O
• Molecular Weight: 150.1778
• Mol File: 1027617-67-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,5,6,7-TETRAHYDRO-2-METHYL-4H-INDAZOL-4-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5,6,7-TETRAHYDRO-2-METHYL-4H-INDAZOL-4-ONE(1027617-67-9)
• EPA Substance Registry System: 2,5,6,7-TETRAHYDRO-2-METHYL-4H-INDAZOL-4-ONE(1027617-67-9)

Safety Data

• Hazardous Substances Data: 1027617-67-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2,5,6,7-Tetrahydro-2-methyl-4h-indazol-4-one is used as a key intermediate in the synthesis of various pharmaceutical compounds for the development of new drugs and therapeutic agents. Its unique chemical structure and properties make it a valuable candidate for further research and development in medicinal chemistry.
Used in Medicinal Chemistry Research:
2,5,6,7-Tetrahydro-2-methyl-4h-indazol-4-one serves as a promising scaffold for the design and synthesis of novel bioactive molecules with potential pharmacological activities. Researchers utilize 2,5,6,7-Tetrahydro-2-methyl-4h-indazol-4-one to explore its potential biological effects and develop new therapeutic agents for various diseases and medical conditions.

Upstream product

• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 504-02-9 1,3-cylohexanedione 
• 499206-33-6 2,5,6,7-tetrahydro-4H-indazol-4-one 
• 74-88-4 methyl iodide 
• 85302-07-4 2-(dimethylaminomethylene)cyclohexane-1,3-dione 
• 912259-10-0 1⁽²⁾,5,6,7-tetrahydro-4H-indazole-4-one 
• 60-34-4 methylhydrazine 

Relevant articles and documents

Design, synthesis and biological evaluation of selective histone deacetylase 6 (HDAC6) inhibitors bearing benzoindazole or pyrazoloindazole scaffold as surface recognition motif

A series of compounds were designed and synthesized based on the compound 11i bearing phenylpyrazole scaffold with histone deacetylase 6 (HDAC6) inhibitory activity. Most of the compounds showed considerable inhibitory activity against HDAC6 and compound

AMINOACYLINDAZOLE IMMUNOMODULATORS FOR TREATMENT OF AUTOIMMUNE DISEASES

2-Acylindazole compounds of formula I or formula II are disclosed. These compounds inhibit Coagulation Factor XIIa. They are useful to treat autoimmune diseases.

AMINOPYRAZOLOQUINAZOLINES

Compounds of general formula (I) wherein the groups R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations whi

NEW AMINOPYRAZOLOQUINAZOLINES

The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferatio

An expedient synthesis of regioisomeric pyrazole-fused cycloalkanones

Described herein is a novel one-pot procedure for the synthesis of pyrazoles through the in situ generation of a monohydrazone of cyclic 1,3-diones and subsequent cyclization with N,N-dimethylformamide dimethyl acetal. This route provides pyrazoles that have limited accessibility by other methods. Georg Thieme Verlag Stuttgart.